Advocating on Behalf of Histology Professionals
NSH represents the interests of histologists by increasing the visibility of the profession among legislative and regulatory public policy makers. By building strategic partnerships and collaborating with allies, NSH can effectively influence the issues that affect our profession and shape the future of histology.
Over the past two years, NSH and its allies have voiced concerns on several key issues including:
Representation Under CLIA
Currently, histology is not recognized under the Clinical Laboratory Improvement Amendments of 1988. NSH recently responded to a request for information, proposing that histology be recognized under CLIA. Learn more.
Fighting Cuts to Reimbursements
In November of 2019, NSH sent a letter to Anthem Blue Cross Blue Shield asking them to reconsider cuts to laboratory testing reimbursement rates that would be detrimental to both laboratories and patients. In January of 2020, NSH and ASCP met with Anthem to further discuss NSH's concerns. Read an update here.
Protecting Access to Medicare Act
PAMA stands for The Protecting Access to Medicare Act. PAMA was passed in 2014, changing the way Medicare pays for, codes and covers clinical diagnostic laboratory tests, or CDLTs. Learn more.
With techs retiring, and histology programs few and far between, histology is feeling the pressures of a workforce shortage. The problem is compounded by a lack of recognition for the histology profession, which can give potential techs the impression they'd be better off in a different field. Learn more.
Want to get involved? Email email@example.com to contribute your voice, or join us at the Legislative Symposium in Washington, DC, March 16-17th.